Table 2.
Comparative susceptibility pattern between indoor and outdoor patients.
| Antimicrobial agents | Hospitalized patients n = 232 | Outdoor patients n = 102 | P value | ||
|---|---|---|---|---|---|
| Sensitive N (%) |
Resistant N (%) |
Sensitive N (%) |
Resistant N (%) |
||
| AML | 22 (9.48) | 210 (90.52) | 28 (27.45) | 74 (72.55) | <0.001 |
| AMC | 45 (19.40) | 187 (80.60) | 37 (36.27) | 65 (63.73) | <0.0001 |
| TZP | 132 (56.90) | 100 (43.10) | 71 (69.61) | 31 (30.39) | <0.03 |
| SCF | 151 (65.09) | 81 (34.91) | 80 (78.43) | 22 (21.57) | <0.02 |
| CEC | 40 (17.24) | 192 (82.76) | 31 (30.39) | 71 (69.61) | <0.006 |
| CAZ | 69 (29.74) | 163 (70.26) | 42 (41.18) | 60 (58.82) | <0.041 |
| CRO | 76 (32.76) | 156 (67.24) | 45 (44.12) | 57 (55.88) | <0.467 |
| FEP | 102 (43.97) | 130 (56.03) | 60 (58.82) | 42 (41.18) | <0.0123 |
| ENX | 75 (32.33) | 157 (67.67) | 42 (41.18) | 60 (58.82) | <0.022 |
| GTX | 95 (40.95) | 137 (59.05) | 54 (52.94) | 48 (47.06) | <0.05 |
| CIP | 108 (46.55) | 124 (53.45) | 60 (58.82) | 42 (41.18) | <0.0388 |
| SPX | 128 (55.17) | 104 (44.83) | 58 (56.86) | 44 (43.14) | <0.0427 |
| MXF | 134 (57.76) | 98 (42.24) | 72 (70.59) | 30 (29.41) | <0.03 |
| E | 35 (15.09) | 197 (84.91) | 29 (28.43) | 73 (71.57) | <0.0137 |
| CLR | 88 (37.93) | 144 (62.07) | 54 (52.94) | 48 (47.06) | <0.0106 |
| CN | 38 (16.38) | 194 (83.62) | 24 (23.53) | 78 (76.47) | <0.0193 |
| AK | 140 (60.34) | 92 (39.66) | 76 (74.51) | 26 (25.49) | <0.01 |
| DO | 12 (5.17) | 220 (94.83) | 22 (21.57) | 80 (78.43) | <0.0001 |
| MEM | 206 (88.79) | 26 (11.21) | 98 (96.08) | 4 (3.92) | <0.032 |
| IPM | 189 (81.47) | 43 (18.53) | 93 (91.18) | 9 (8.82) | <0.0242 |